Aurobindo, Hetero, and Vivimed Class Action Settlements in Arkansas

All Aurobindo, Hetero, and Vivimed class action lawsuits and settlements available to Arkansas residents.

Arkansas residents have 1 active class action settlements involving Aurobindo, Hetero, and Vivimed that they can file claims for right now. Open settlements include $15.2M Valsartan, Losartan and Irbesartan class action settlement.

Class Action Buddy automatically files Aurobindo, Hetero, and Vivimed claims for Arkansas residents in under 60 seconds — no paperwork, no mailing, no proof of purchasey/proof-of-purchase/" style="color:#5D82F2;text-decoration:none;font-weight:500;">proof of purchase needed for most settlements.

About Aurobindo, Hetero, and Vivimed Class Actions in Arkansas

Arkansas residents affected by contaminated blood pressure medications from Aurobindo, Hetero, and Vivimed have legal options under the state's Deceptive Trade Practices Act, which provides broader consumer protections than federal law and allows for treble damages in certain cases. While these pharmaceutical companies don't maintain major manufacturing facilities in Arkansas, their generic medications were widely distributed through Arkansas pharmacies and healthcare systems, including major chains like CVS and Walgreens that serve rural communities statewide. The $15.2 million Valsartan, Losartan and Irbesartan class action settlement specifically addresses NDMA contamination issues from these manufacturers. Arkansas residents filing class action claims must be aware that the state follows a three-year statute of limitations for personal injury claims, though discovery rules may extend this period. The Arkansas Attorney General's office has been particularly active in pharmaceutical litigation, and residents can benefit from the state's consumer protection framework that often provides additional remedies beyond federal class action settlements.

How does Arkansas's consumer protection law affect my Aurobindo, Hetero, and Vivimed settlement claim?

Arkansas's Deceptive Trade Practices Act allows for enhanced damages beyond the federal settlement amounts, potentially including attorney fees and treble damages. This state law can provide additional compensation even if you participate in the $15.2 million federal settlement for contaminated blood pressure medications.

Are Arkansas residents eligible for the Aurobindo, Hetero, and Vivimed blood pressure medication settlement?

Yes, Arkansas residents who took contaminated Valsartan, Losartan, or Irbesartan manufactured by these companies between 2012-2018 can participate in the $15.2 million settlement. You must have purchased the medications from Arkansas pharmacies and meet the settlement's specific eligibility requirements.

What documentation do Arkansas residents need for Aurobindo, Hetero, and Vivimed claims?

Arkansas residents need pharmacy records showing purchases of the affected medications, preferably with NDC numbers identifying Aurobindo, Hetero, or Vivimed as manufacturers. Medical records documenting any health issues and proof of Arkansas residency during the relevant time period are also essential for claim validation.

Tips for Arkansas Residents Filing Aurobindo, Hetero, and Vivimed Claims

Arkansas residents filing Aurobindo, Hetero, and Vivimed claims should gather pharmacy records immediately, as some Arkansas pharmacies purge records after seven years. Contact your insurance company for medication history if pharmacy records are unavailable. File claims promptly under Arkansas's three-year statute of limitations, though the discovery rule may extend deadlines for cancer diagnoses. Consider consulting Arkansas attorneys familiar with pharmaceutical litigation, as state consumer protection laws may provide additional remedies beyond federal settlements. The Arkansas Attorney General's office maintains resources for consumer fraud victims that can supplement your federal class action claim.

More Arkansas Resources